Copper induces type II nitric oxide synthase in vivo

Free Radical Biology and Medicine

Volumn 34, Issue 10, 2003, Pages 1253-1262

  Cuzzocrea, Salvatore ^a   Persichini, Tiziana ^b   Dugo, Laura ^a   Colasanti, Marco ^b   Musci, Giovanni ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

Author keywords

Copper; Free radicals; Nitric oxide; NOS; Oxidative stress

Indexed keywords

1 N 6 IMINOETHYLLYSINE; 3 NITROTYROSINE; AMINOGUANIDINE; BACTERIUM LIPOPOLYSACCHARIDE; COPPER; LYSINE DERIVATIVE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PEROXYNITRITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME SYNTHESIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER; LUNG; LUNG HOMOGENATE; MALE; MEDIATOR RELEASE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION;

BACTERIA (MICROORGANISMS);

EID: 0242669205     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00110-2     Document Type: Article

References (48)

1. Musci G., Bonaccorsi di Patti M.C., Fagiolo U., Calabrese L. Age-related changes in human ceruloplasmin. Evidence for oxidative modifications. J. Biol. Chem. 268:1993;13388-13395.
2. Brenner A.J., Harris E.D. A quantitative test for copper using bicinchoninic acid. Anal. Biochem. 226:1995;80-84.
3. Barone A., Ebesh O., Harper R.G., Wapnir R.A. Placental copper transport in rats effects of elevated dietary zinc on fetal copper, iron and metallothionein . J. Nutr. 128:1998;1037-1041.
4. Lonnerdal B., Jayawickrama L., Lien E.L. Effect of reducing the phytate content and of partially hydrolyzing the protein in soy formula on zinc and copper absorption and status in infant rhesus monkeys and rat pups. Am. J. Clin. Nutr. 69:1999;490-496.
5. Abba M., De Luca J.C., Mattioli G., Zaccardi E., Dulout F.N. Clastogenic effect of copper deficiency in cattle. Mutat. Res. 466:2000;51-55.
6. Klevay L.M. Cardiovascular disease from copper deficiency - a history. J. Nutr. 130:2000;489S-492S.
7. Harris E.D. Cellular copper transport and metabolism. Annu. Rev. Nutr. 20:2000;291-310.
8. Gitlin J.D. Aceruloplasminemia. Pediatr. Res. 44:1998;271-276.
9. Hawkins A.S., Stein R.M., Gaines B.I., Deutsch T.A. Ocular deposition of copper associated with multiple myeloma. Am. J. Ophthalmol. 131:2001;257-259.
10. Molteni A., Ward W.F., Kim Y.T., Shetty R., Brizio-Molteni L., Giura R., Ribner H., Lomont M. Serum copper concentration as an index of clinical lung injury. Adv. Exp. Med. Biol. 258:1989;273-285.
11. Sondheimer J.H., Mahajan S.K., Rye D.L., Abu-Hamdan D.K., Migdal S.D., Prasad A.S., McDonald F.D. Elevated plasma copper in chronic renal failure. Am. J. Clin. Nutr. 47:1988;896-899.
12. Scarpa R., Oriente P., Pucino A., Torella M., Vignone L., Gattozzi D. [Hypercupremia a marker of articular phlogosis?] . Boll. Soc. Ital. Biol. Sper. 60:1984;633-639.
13. Ferns G.A., Lamb D.J., Taylor A. The possible role of copper ions in atherogenesis the Blue Janus . Atherosclerosis. 133:1997;139-152.
14. Reunanen A., Knekt P., Marniemi J., Maki J., Maatela J., Aromaa A. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur. J. Clin. Nutr. 50:1996;431-437.
15. Wisdom S.J., Wilson R., McKillop J.H., Walker J.J. Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am. J. Obstet. Gynecol. 165:1991;1701-1704.
16. Plane F., Wigmore S., Angelini G.D., Jeremy J.Y. Effect of copper on nitric oxide synthase and guanylyl cyclase activity in the rat isolated aorta. Br. J. Pharmacol. 121:1997;345-350.
17. Ohnishi T., Ishizaki T., Sasaki F., Ameshima S., Nakai T., Miyabo S., Matsukawa S. The effect of Cu2+ on rat pulmonary arterial rings. Eur. J. Pharmacol. 319:1997;49-55.
18. Chiarugi A., Pitari G.M., Costa R., Ferrante M., Villari L., Amico-Roxas M., Godfraind T., Bianchi A., Salomone S. Effect of prolonged incubation with copper on endothelium-dependent relaxation in rat isolated aorta. Br. J. Pharmacol. 136:2002;1185-1193.
19. Cappelli-Bigazzi M., Ambrosio G., Musci G., Battaglia C., Bonaccorsi di Patti M.C., Golino P., Ragni M., Chiariello M., Calabrese L. Ceruloplasmin impairs endothelium-dependent relaxation of rabbit aorta. Am. J. Physiol. 273:1997;H2843-H2849.
20. Demura Y., Ishizaki T., Ameshima S., Okamura S., Hayashi T., Matsukawa S., Miyamori I. The activation of nitric oxide synthase by copper ion is mediated by intracellular Ca2+ mobilization in human pulmonary arterial endothelial cells. Br. J. Pharmacol. 125:1998;1180-1187.
21. Bianchini A., Musci G., Calabrese L. Inhibition of endothelial nitric-oxide synthase by ceruloplasmin. J. Biol. Chem. 274:1999;20265-20270.
22. Caputi A.P., Rossi F., Carney K., Brezenoff H.E. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J. Pharmacol. Exp. Ther. 215:1980;309-316.
23. Colasanti M., Persichini T., Venturini G., Polticelli F., Musci G. Modulation of the nitric oxide pathway by copper in glial cells. Biochem. Biophys. Res. Commun. 275:2000;776-782.
24. Musci G., Bonaccorsi di Patti M.C., Carlini P., Calabrese L. Ceruloplasmin in human plasma and its relationships with the copper- albumin complex. Eur. J. Biochem. 210:1992;635-640.
25. Southan G.J., Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol. 51:1996;383-394.
26. Moore W.M., Webber R.K., Jerome G.M., Tjoeng F.S., Misko T.P., Currie M.G. L-N6-(1-iminoethyl)lysine a selective inhibitor of inducible nitric oxide synthase . J. Med. Chem. 37:1994;3886-3888.
27. Bergamini S., Rota C., Canali R., Staffieri M., Daneri F., Bini A., Giovannini F., Tomasi A., Iannone A. N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase. Nitric Oxide. 5:2001;349-360.
28. Mailman D., Guntuku S., Bhuiyan M.B., Murad F. Organ sites of lipopolysaccharide-induced nitric oxide production in the anesthetized rat. Nitric Oxide. 5:2001;243-251.
29. Osakabe, N.; Yasuda, A.; Natsume, M.; Sanbongi, C.; Kato, Y.; Osawa, T.; Yoshikawa, T. Rosmarinic acid, a major polyphenolic component of Perilla frutescens, reduces lipopolysaccharide (LPS)-induced liver injury in D-galactosamine (D-GalN)-sensitized mice. Free Radic. Biol. Med. 33:798-2002.
30. Tian L., Lawrence D.A. Metal-induced modulation of nitric oxide production in vitro by murine macrophages lead, nickel, and cobalt utilize different mechanisms . Toxicol. Appl. Pharmacol. 141:1996;540-547.
31. Perry J.M., Marletta M.A. Effects of transition metals on nitric oxide synthase catalysis. Proc. Natl. Acad. Sci. USA. 95:1998;11101-11106.
32. Perry J.M., Zhao Y., Marletta M.A. Cu2+ and Zn2+ inhibit nitric-oxide synthase through an interaction with the reductase domain. J. Biol. Chem. 275:2000;14070-14076.
33. Linder M.C., Lomeli N.A., Donley S., Mehrbod F., Cerveza P., Cotton S., Wotten L. Copper transport in mammals. Adv. Exp. Med. Biol. 448:1999;1-16.
34. Harris E.D. Copper homeostasis the role of cellular transporters . Nutr. Rev. 59:2001;281-285.
35. Nilsson B.O. Biological effects of aminoguanidine an update . Inflamm. Res. 48:1999;509-515.
36. Fujisawa H., Nishikawa T., Zhu B.H., Nishimura Y., Shimizu M., Kimoto M., Higuchi K., Hosokawa M. Aminoguanidine supplementation delays the onset of senescence in vitro in dermal fibroblast-like cells from senescence-accelerated mice. J. Gerontol. A Biol. Sci. Med. Sci. 54:1999;B276-B282.
37. Titheradge M.A. Nitric oxide in septic shock. Biochim. Biophys. Acta. 1411:1999;437-455.
38. Brady T.C., Chang L.Y., Day B.J., Crapo J.D. Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-kappa B activation. Am. J. Physiol. 273:1997;L1002-L1006.
39. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1986;1370-1376.
40. Evans P.J., Evans R.W., Bomford A., Williams R., Halliwell B. Metal ions catalytic for free radical reactions in the plasma of patients with fulminant hepatic failure. Free Radic. Res. 20:1994;139-144.
41. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol. 9:1996;836-844.
42. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 391:1998;393-397.
43. Swain J.A., Darley-Usmar V., Gutteridge J.M. Peroxynitrite releases copper from caeruloplasmin implications for atherosclerosis . FEBS Lett. 342:1994;49-52.
44. Cousins R.J. Absorption, transport, and hepatic metabolism of copper and zinc special reference to metallothionein and ceruloplasmin . Physiol. Rev. 65:1985;238-309.
45. Gitlin J.D. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J. Biol. Chem. 263:1988;6281-6287.
46. Colasanti M., Suzuki H. The dual personality of NO. Trends Pharmacol. Sci. 21:2000;249-252.
47. Hu J., Castets F., Guevara J.L., Van Eldik L.J. S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 271:1996;2543-2547.
48. Matsui L.I., Suzuki M., Hayashi N., Hu J., Van Eldik L.J., Titani K., Nishikimi M. Copper-dependent formation of disulfide-linked dimer of S100B protein. Arch. Biochem. Biophys. 374:2000;137-141.